Novartis Capacity Update April 2025: Large Molecule Development

This presentation will highlight the extensive contract manufacturing capabilities of Novartis, with a focus on tech transfer, clinical drug substance production, and commercial drug substance manufacturing. Attendees will gain insights into how Novartis leverages its global manufacturing network — spanning Singapore, Europe, and the United States — to deliver high-quality, reliable services at every stage of development and commercialization. The session will also explore how Novartis’ expertise in process optimization, scalability, and regulatory compliance supports clients in bringing their therapies to market efficiently and successfully.